Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment

BACKGROUND: Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease resulting from exposure to drugs causing inflammation and possibly interstitial fibrosis. Antineoplastic drugs are the primary cause of DIILD, accounting for 23%-51% of cases, with bleomycin, everolimus...

Descripción completa

Detalles Bibliográficos
Autores principales: Conte, P., Ascierto, P.A., Patelli, G., Danesi, R., Vanzulli, A., Sandomenico, F., Tarsia, P., Cattelan, A., Comes, A., De Laurentiis, M., Falcone, A., Regge, D., Richeldi, L., Siena, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881716/
https://www.ncbi.nlm.nih.gov/pubmed/35219244
http://dx.doi.org/10.1016/j.esmoop.2022.100404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881716/
https://www.ncbi.nlm.nih.gov/pubmed/35219244
http://dx.doi.org/10.1016/j.esmoop.2022.100404

Ejemplares similares